TYRVAYA: payments to doctors
Payments that named TYRVAYA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.2M
- Providers
- 19,423
- Transactions
- 81,970
- Average per transaction
- $64
The per-transaction average — $64 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,423 providers the average total is $269, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Oyster Point Pharma, Inc. | $5,231,662 | 100.0% |
| Mylan Inc. | $101 | 0.0% |